Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia
Alexander Kreuter, Maximiliano J. Licciardi-Fernandez, Sven‐Niklas Burmann, Alexandros Paschos, Alena‐Lioba Michalowitz
Abstract
We read with great interest the recently published article by Joos et al. on the successful use of baricitinib for cutaneous lupus erythematosus. The authors presented a heavily pretreated case of subacute cutaneous lupus erythematosus (SCLE) with almost complete clearance following 6 months of baricitinib therapy. We would like to add our experiences of baricitinib for SCLE in a patient with concomitant frontal fibrosing alopecia.
Topics & Concepts
MedicineSubacute cutaneous lupus erythematosusConcomitantDermatologySystemic lupus erythematosusLupus erythematosusCutaneous Lupus ErythematosusConnective tissue diseaseAutoimmune diseaseSurgeryPathologyDiseaseImmunologyAntibodySystemic Lupus Erythematosus ResearchChronic Lymphocytic Leukemia ResearchAutoimmune Bullous Skin Diseases